Studies show that antidepressants don’t always work. One psychologist explains how to take control of negative thoughts ...

Neuroscience company Neumora Therapeutics (NMRA) announced today that its experimental treatment for depression, Navacaprant, ...

Neumora Therapeutics Inc.’s shares plummeted after the company’s experimental drug failed to show a benefit in a final-stage ...

Those on the extreme end of the depression spectrum face symptoms that impact their daily activities too and not just their ...

About a third of them do not achieve adequate relief from traditional antidepressant medications and psychotherapy. The Pine ...

In zebrafish, ketamine causes changes a brain circuit involved in "giving up." That may help explain how the drug helps ...

Depression is a common mental health condition and mood disorder that causes a persistent feeling of sadness and loss of ...

The well-funded biotech lost most of its value after its drug flunked a late-stage trial. One analyst described the results ...

After six weeks, both the treatment group and the placebo group experienced an average 12.5-point reduction on the Montgomery-Åsberg Depression Rating Scale (MADRS). The drug also fell short in i ...

Neumora Therapeutics, Inc. (NASDAQ:NMRA) stock traded lower after the company released data from the Phase 3 KOASTAL-1 Study ...